REGN's lead drug, Eylea, faces a rapid decline in sales, which has impacted overall performance, even though Dupixent maintains momentum. We advise investors to wait and watch for now.

("Curis") (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, yesterday presented data from the TakeAim ...

AiViva Biopharma Inc., a clinical-stage biotechnology company, announced the receipt of FDA clearance for testing AIV001 (axitinib) by intradermal injection with their formulation in facial skin.

Advanced Dermatology P.C., with 14 offices on LI, violated the American Disabilities Act, the U.S. Attorney said.

The research team at UQ has secured a grant of $344,000 from the National Foundation for Medical Research and Innovation.

Moles or birthmarks can appear anywhere on the body, including under the nails. While most moles are harmless, some may ...

The work introduces a valuable new method for depleting the ribosomal RNA from bacterial single-cell RNA sequencing libraries and shows that this method is applicable to studying the heterogeneity in ...

A biopsy showed my bump was an aggressive form of basal cell carcinoma. Dr ... "We are seeing more advanced cancers in younger patients," he said. "We are seeing more bad outcomes as a result ...

This discovery could pave the way for new therapies for patients with few options and marks significant progress in understanding how advanced prostate cancer becomes resistant to androgen ...

Each type of cell has a unique role, and knowing what all the cells do can help scientists better understand health and diseases such as cancer. Scientists focused on certain organs — plotting the ...